hydroksyurea
Hydroxyurea, also known as hydroksyurea in Polish, is a medication classified as an antimetabolite. It inhibits DNA synthesis by blocking ribonucleotide reductase, an enzyme that converts ribonucleotides to deoxyribonucleotides necessary for DNA replication.
Clinical uses include myeloproliferative neoplasms such as polycythemia vera and essential thrombocythemia, where it helps control
Pharmacology and administration: Hydroxyurea is usually taken by mouth as tablets. Absorption is rapid; responses in
Safety and monitoring: Common adverse effects include bone marrow suppression (neutropenia and thrombocytopenia), nausea, vomiting, mucositis,
Societal status: Hydroxyurea is available in generic form and is prescribed by hematologists and oncologists in